Andrea Cuconati,Haitao Guo,Timothy M. Block,Ju-Tao Guo,Xiaodong Xu,Huagang Lu,Dawei Cai
申请号：
US14382074
公开号：
US09657013B2
申请日:
2013.02.28
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Pharmaceutical compositions of the invention comprise covalently closed circular DNA formation inhibitors having a disease-modifying action in the treatment of diseases associated with the formation of covalently closed circular DNA that include hepatitis B infection, and any disease involving formation of covalently closed circular DNA.
